Pru p 3 sublingual immunotherapy ultra-rush protocol is safe and clinically effective

13Citations
Citations of this article
21Readers
Mendeley users who have this article in their library.

Abstract

Introduction. Sublingual immunotherapy (SLIT) with Pru p 3 can prevent severe allergic reactions to LTP-containing foods but the standard initiation protocol is time-consuming. Aim. Establish the safety of a novel ultra-rush initiation protocol for SLIT with Pru p 3. Methods. Prospective study comparing the side effects of the standard vs novel ultra-rush initiation protocols of SLIT with Pru p 3 in patients with anaphylaxis to LTP. Results. Fifteen patients were included (standard initiation, 5; ultra-rush initiation, 10), 80% females. All patients had oropharyngeal pruritus during initiation, 80% with spontaneous recovery, but no other gastro-intestinal, respiratory, cutaneous or systemic side effects occurred in any patient of both groups. Conclusion. The novel ultra-rush protocol halved the build-up time without increasing side effects.

Cite

CITATION STYLE

APA

Moura, A. L., Pereira, C., Regateiro, F. S., Azevedo, J., Todo Bom, A., & Carrapatoso, I. (2019). Pru p 3 sublingual immunotherapy ultra-rush protocol is safe and clinically effective. European Annals of Allergy and Clinical Immunology, 51(5), 206–212. https://doi.org/10.23822/EurAnnACI.1764-1489.99

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free